黑人缺血性卒中患者血管内治疗利用不足:州与全国队列分析
黑人患者到达EVT医院或综合卒中中心的比例与白人相似,但EVT率较低(4.1% vs 5.3%;调整相对风险0.76 [0.66-0.88];P<0.001),全国样本验证了该发现(调整相对风险0.87 [0.77-0.98];P=0.024)。西班牙裔与白人患者间无差异。
要点
- 黑人患者到达EVT医院或综合卒中中心的比例与白人相似,无差异证据。
- 西班牙裔与白人患者EVT率无差异,全国样本验证黑人EVT利用较低。
核心结论
- 未发现黑人患者就诊于EVT医院或综合卒中中心存在差异,但黑人患者EVT率较低。
研究设计与样本
- 回顾性、基于人群的研究,使用2019年德克萨斯州住院患者公共数据文件,通过ICD-10诊断和操作代码识别急性缺血性卒中病例和EVT使用。
- 共纳入40814例急性缺血性卒中病例,其中54%白人、17%黑人、21%西班牙裔。
- 采用多变量改良泊松回归估计调整相对风险,并调整患者危险因素和社会经济特征;使用2017年全国住院患者样本进行患者层面分析以验证州内发现。
主要发现
- 黑人患者到达EVT医院的比例与白人相似(62% vs 62%,P=0.21),到达综合卒中中心的比例更高(45% vs 39%,P<0.001)。
- 黑人患者EVT率低于白人(4.1% vs 5.3%;调整相对风险0.76 [0.66-0.88];P<0.001)。
- 西班牙裔与白人患者EVT率无差异。
- 在早期时间窗到达并接受静脉重组组织型纤溶酶原激活剂的患者亚组中,黑人EVT率较低(调整相对风险0.77 [0.61-0.98];P=0.032)。
- 在非综合卒中中心(3.0% vs 5.5%,P<0.001)和综合卒中中心(7.9% vs 10.4%,P<0.001)住院的亚组中,黑人EVT率均较低,而白人与西班牙裔之间无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Endovascular therapy (EVT) is a very effective treatment but relies on specialized capabilities that are not available in every hospital where acute ischemic stroke is treated. Here, we assess whether access to and utilization of this therapy has extended uniformly across racial and ethnic groups. METHODS: We conducted a retrospective, population-based study using the 2019 Texas Inpatient Public Use Data File. Acute ischemic stroke cases and EVT use were identified using the International Classification of Diseases, Tenth Revision (ICD-10) diagnosis and procedure codes. We examined EVT utilization by race/ethnicity and performed patient- and hospital-level analyses. To validate state-specific findings, we conducted patient-level analyses using the 2017 National Inpatient Sample for national estimates. To assess independent associations between race/ethnicity and EVT, multivariable modified Poisson regressions were fitted and adjusted relative risks were estimated accounting for patient risk factors and socioeconomic characteristics. RESULTS: Among 40 814 acute ischemic stroke cases in Texas in 2019, 54% were White, 17% Black, and 21% Hispanic. Black patients had similar admissions to EVT-performing hospitals and greater admissions to comprehensive stroke centers (CSCs) compared with White patients (EVT 62% versus 62%, P=0.21; CSCs 45% versus 39%, P<0.001) but had lower EVT rates (4.1% versus 5.3%; adjusted relative risk, 0.76 [0.66-0.88]; P<0.001). There were no differences in EVT rates between Hispanic and White patients. Lower rates of EVT among Black patients were consistent in the subgroup of patients who arrived in early time windows and received intravenous recombinant tissue-type plasminogen activator (adjusted relative risk, 0.77 [0.61-0.98]; P=0.032) and the subgroup of those admitted to EVT-performing hospitals in both non-CSC (3.0% versus 5.5, P<0.001) and CSC hospitals (7.9% versus 10.4%, P<0.001) while there were no differences between Whites and Hispanic patients. Nationwide sample data confirmed this finding of lower utilization of EVT among Black patients (adjusted relative risk, 0.87 [0.77-0.98]; P=0.024). CONCLUSIONS: We found no evidence of disparity in presentation to EVT-performing hospitals or CSCs; however, lower rates of EVT were observed in Black patients.
引用
- Kim Y, Sharrief A, Kwak MJ, et al. Underutilization of Endovascular Therapy in Black Patients With Ischemic Stroke: An Analysis of State and Nationwide Cohorts. Stroke. 2022. PMID: 35067099. doi:10.1161/STROKEAHA.121.035714
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。